Adidas AG (0OLD)
London Exchange · UK · prices in EUR · close of 21 Oct 2026
Key indicators
| Last close | EUR 160.70 |
|---|---|
| 52-week range | 127.54 – 192.71 |
| Return, 1 month / 3 months | +9.0% / −8.9% |
| Return, 1 year / 3 years | −14.1% / −2.5% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 33.8% |
| Worst drawdown (1 year) | -32.5% |
| Average daily value traded | 48.14M EUR |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Adidas is a German sportswear company that designs, makes and sells athletic footwear, clothing and accessories. Its products range from running shoes and football boots to training wear and lifestyle apparel, sold under the Adidas brand and formerly under Reebok. Customers include professional athletes, sports teams, amateur sportspeople and everyday consumers, reached through own retail stores, franchise partners and sporting goods retailers. The company is based in Herzogenaurach, Germany, and markets its goods around the world.
On this site Adidas AG appears as a stock on the London Exchange (UK), code 0OLD, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Adidas AG (0OLD) trades on the London Exchange in UK. It last closed at EUR 160.70 on 21 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 1,943 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 14.1% and over the last three months it fell 8.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 49 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 4.4% | ||
| From 52-week high | -16.0% | ||
| Momentum | 40 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.9% | ||
| 6-month return | 15.0% | ||
| 12-month return, skipping the last month | -21.2% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.5% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 48.14M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +4.1% |
|---|---|
| 1 month | +9.0% |
| 3 months | −8.9% |
| 6 months | +15.0% |
| 1 year | −14.1% |
| 3 years | −2.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 149.59 / 153.89 |
|---|---|
| Golden / death cross (60 days) | Death, 14 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.20 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 May 2026 | EUR 2.8000 |
| 16 May 2025 | EUR 2.0000 |
| 17 May 2024 | EUR 0.7000 |
| 12 May 2023 | EUR 0.7000 |
| 13 May 2022 | EUR 3.3000 |
| 13 May 2021 | EUR 3.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.